Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.85 - $15.47 $554,580 - $723,996
-46,800 Reduced 22.69%
159,500 $2.34 Million
Q2 2024

Aug 14, 2024

BUY
$12.93 - $18.45 $261,186 - $372,690
20,200 Added 10.85%
206,300 $2.98 Million
Q1 2024

May 15, 2024

BUY
$14.37 - $16.46 $155,196 - $177,768
10,800 Added 6.16%
186,100 $3.03 Million
Q4 2023

Feb 14, 2024

SELL
$8.6 - $14.94 $194,360 - $337,644
-22,600 Reduced 11.42%
175,300 $2.61 Million
Q3 2023

Nov 14, 2023

BUY
$9.81 - $12.62 $410,058 - $527,516
41,800 Added 26.78%
197,900 $2.22 Million
Q2 2023

Aug 14, 2023

SELL
$8.08 - $10.37 $725,584 - $931,225
-89,800 Reduced 36.52%
156,100 $1.57 Million
Q1 2023

May 15, 2023

SELL
$8.79 - $14.58 $196,895 - $326,592
-22,400 Reduced 8.35%
245,900 $2.31 Million
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $592,884 - $704,340
-51,600 Reduced 16.13%
268,300 $3.28 Million
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $2.5 Million - $6.52 Million
201,100 Added 169.28%
319,900 $3.97 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.